Eli Lilly and Co (NYSE:LLY)
| 154.11 Delayed Data As of Sep 18 |  +1.64 / +1.08%Today’s Change | 101.36 Today|||52-Week Range 170.75 | +17.26% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 152.47 |
| Today’s open | 151.78 |
| Day’s range | 151.78 - 154.52 |
| Volume | 13,210,113 |
| Average volume (3 months) | 3,446,458 |
| Market cap | $141.6B |
Data as of 4:19pm ET, 09/18/2020
Growth & Valuation
| Earnings growth (last year) | +58.64% |
| Earnings growth (this year) | +19.95% |
| Earnings growth (next 5 years) | +14.90% |
| Revenue growth (last year) | -9.11% |
| P/E ratio | 25.2 |
| Price/Sales | 5.51 |
| Price/Book | 54.39 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | +0.51 | +0.91% |
| ABBVAbbVie | +0.47 | +0.52% |
| BMYBristol-Myers Squibb | -0.14 | -0.24% |
| SNYSanofi | +0.37 | +0.71% |
Data as of 4:19pm ET, 09/18/2020
Financials
| Next reporting date | October 27, 2020 |
| EPS forecast (this quarter) | $1.72 |
| Annual revenue (last year) | $22.3B |
| Annual profit (last year) | $4.6B |
| Net profit margin | 20.78% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
